Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP

Neuropharmacology

Volumn 49, Issue 7, 2005, Pages 1053-1066

  Yan, Q J ^a   Rammal, M ^a   Tranfaglia, M ^b   Bauchwitz, R P ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b FRAXA Research Foundation   (United States)

Author keywords

Audiogenic seizures; fmr1; Fragile X; mGluR; MPEP; Open field

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; FRAGILE X MENTAL RETARDATION PROTEIN; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST;

ALLELE; ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; DOSE RESPONSE; DRUG ACTIVITY; FEMALE; FRAGILE X SYNDROME; GENE MUTATION; GENETIC ANALYSIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OPEN FIELD BEHAVIOR; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; WILD TYPE;

AGING; ALLELES; ANIMALS; DRUG SYNERGISM; EPILEPSY, REFLEX; EXPLORATORY BEHAVIOR; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; PYRIDINES; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 24344457816     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.06.004     Document Type: Article

References (59)

1. A. Aiba, M. Kano, C. Chen, M.E. Stanton, G.D. Fox, K. Herrup, T.A. Zwingman, and S. Tonegawa Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice Cell 79 1994 377 388
2. L.N. Antar, R. Afroz, J.B. Dictenberg, R.C. Carroll, and G.J. Bassell Metabotropic glutamate receptor activation regulates Fragile X mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses J. Neurosci. 24 2004 2648 2655
3. R. Anwyl Metabotropic glutamate receptors: electrophysiological properties and role in plasticity Brain Res. Brain Res. Rev. 29 1999 83 120
4. S. Attarian, and M. Amalric Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat Eur. J. Neurosci. 9 1997 809 816
5. C.E. Bakker, and D-B FX Consortium Fmr1 knockout mice: a model to study fragile X mental retardation Cell 78 1994 23 33
6. Z.I. Bashir, Z.A. Bortolotto, C.H. Davies, N. Berretta, A.J. Irving, A.J. Seal, J.M. Henley, D.E. Jane, J.C. Watkins, and G.L. Collingridge Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors Nature 363 1993 347 350
7. M.F. Bear, K.M. Huber, and S.T. Warren The mGluR theory of fragile X mental retardation Trends Neurosci. 27 2004 370 377
8. Z.A. Bortolotto, Z.I. Bashir, C.H. Davies, and G.L. Collingridge A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiation Nature 368 1994 740 743
9. Z.A. Bortolotto, and G.L. Collingridge Activation of glutamate metabotropic receptors induces long-term potentiation Eur. J. Pharmacol. 214 1992 297 298
10. C.S. Busse, J. Brodkin, D. Tattersall, J.J. Anderson, N. Warren, L. Tehrani, L.J. Bristow, M.A. Varney, and N.D. Cosford The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4- yl)ethynyl]pyridine (MTEP) in rodent models of anxiety Neuropsychopharmacology 29 2004 1971 1979
11. N. Camodeca, N.A. Breakwell, M.J. Rowan, and R. Anwyl Induction of LTD by activation of group I mGluR in the dentate gyrus in vitro Neuropharmacology 38 1999 1597 1606
12. A.G. Chapman, K. Nanan, M. Williams, and B.S. Meldrum Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893) Neuropharmacology 39 2000 1567 1574
13. L. Chen, and M. Toth Fragile X mice develop sensory hyperreactivity to auditory stimuli Neuroscience 103 2001 1043 1050
14. S. Chuang, Q. Yan, R.P. Bauchwitz, and R.S.K. Wong Synaptic Activation of Gp I mGluRs is Epileptogenic in Hippocampal Slices of FMRP Knock-out Mice 2004 Society for Neuroscience San Diego
15. T.A. Comery, J.B. Harris, P.J. Willems, B.A. Oostra, S.A. Irwin, I.J. Weiler, and W.T. Greenough Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits Proc. Natl Acad. Sci. U.S.A. 94 1997 5401 5404
16. F. Gasparini, K. Lingenhohl, N. Stoehr, P.J. Flor, M. Heinrich, I. Vranesic, M. Biollaz, H. Allgeier, R. Heckendorn, S. Urwyler, M.A. Varney, E.C. Johnson, S.D. Hess, S.P. Rao, A.I. Sacaan, E.M. Santori, G. Velicelebi, and R. Kuhn 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist Neuropharmacology 38 1999 1493 1503
17. V.J. Hinton, W.T. Brown, K. Wisniewski, and R.D. Rudelli Analysis of neocortex in three males with the fragile X syndrome Am. J. Med. Genet. 41 1991 289 294
18. K.M. Huber, S.M. Gallagher, S.T. Warren, and M.F. Bear Altered synaptic plasticity in a mouse model of fragile X mental retardation Proc. Natl Acad. Sci. U.S.A. 99 2002 7746 7750
19. K.M. Huber, J.C. Roder, and M.F. Bear Chemical induction of mGluR5- and protein synthesis-dependent long-term depression in hippocampal area CA1 J. Neurophysiol. 86 2001 321 325
20. S.A. Irwin, B. Patel, M. Idupulapati, J.B. Harris, R.A. Crisostomo, B.P. Larsen, F. Kooy, P.J. Willems, P. Cras, P.B. Kozlowski, R.A. Swain, I.J. Weiler, and W.T. Greenough Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination Am. J. Med. Genet. 98 2001 161 167
21. E.C. Jenkins, W.T. Brown, J. Brooks, C.J. Duncan, R.D. Rudelli, and H.M. Wisniewski Experience with prenatal fragile X detection Am. J. Med. Genet. 17 1984 215 239
22. 14C]-2-deoxyglucose autoradiographic study J. Neurosci. 17 1997 4415 4425
23. H.O. Kiess Statistical Concepts for the Behavioral Sciences third ed. 2002 Allyn & Bacon Boston
24. B. Laggerbauer, D. Ostareck, E. Keidel, A. Ostareck-Lederer, and U. Fischer Evidence that fragile X mental retardation protein is a negative regulator of translation Hum. Mol. Genet. 10 2001 329 338
25. Z. Li, Y. Zhang, L. Ku, K.D. Wilkinson, S.T. Warren, and Y. Feng The fragile X mental retardation protein inhibits translation via interacting with mRNA Nucleic Acids Res. 29 2001 2276 2283
26. D.J. Linden Long-term synaptic depression in the mammalian brain Neuron 12 1994 457 472
27. A.J. McGeehan, P.H. Janak, and M.F. Olive Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, d-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice Psychopharmacology (Berl) 174 2004 266 273
28. N. McGuinness, R. Anwyl, and M. Rowan The effects of trans-ACPD on long-term potentiation in the rat hippocampal slice Neuroreport 2 1991 688 690
29. D. Meeker, J.H. Kim, and P. Vezina Depletion of dopamine in the nucleus accumbens prevents the generation of locomotion by metabotropic glutamate receptor activation Brain Res. 812 1998 260 264
30. H.B. Michelson, and E.W. Lothman An in vivo electrophysiological study of the ontogeny of excitatory and inhibitory processes in the rat hippocampus Brain Res. Dev. Brain Res. 47 1989 113 122
31. S.A. Musumeci, P. Bosco, G. Calabrese, C. Bakker, G.B. De Sarro, M. Elia, R. Ferri, and B.A. Oostra Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome Epilepsia 41 2000 19 23
32. S.A. Musumeci, R.J. Hagerman, R. Ferri, P. Bosco, B. Dalla Bernardina, C.A. Tassinari, G.B. De Sarro, and M. Elia Epilepsy and EEG findings in males with fragile X syndrome Epilepsia 40 1999 1092 1099
33. A. Nadlewska, H. Car, R.J. Wisniewska, and K. Wisniewski Behavioral effects of the selective blockade of metabotropic glutamate receptor subtype 5 in experimental hypoxia Pol. J. Pharmacol. 54 2002 95 102
34. E.A. Nimchinsky, A.M. Oberlander, and K. Svoboda Abnormal development of dendritic spines in FMR1 knock-out mice J. Neurosci. 21 2001 5139 5146
35. S.H. Oliet, R.C. Malenka, and R.A. Nicoll Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells Neuron 18 1997 969 982
36. K. Ossowska, J. Konieczny, S. Wolfarth, J. Wieronska, and A. Pilc Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats Neuropharmacology 41 2001 413 420
37. A.M. Peier, K.L. McIlwain, A. Kenneson, S.T. Warren, R. Paylor, and D.L. Nelson (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features Hum. Mol. Genet. 9 2000 1145 1159
38. S. Pellow, and S.E. File Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat Pharmacol. Biochem. Behav. 24 1986 525 529
39. S. Petersen, C. Bomme, C. Baastrup, A. Kemp, and G.R. Christoffersen Differential effects of mGluR1 and mGluR5 antagonism on spatial learning in rats Pharmacol. Biochem. Behav. 73 2002 381 389
40. A. Pilc, A. Klodzinska, P. Branski, G. Nowak, A. Palucha, B. Szewczyk, E. Tatarczynska, E. Chojnacka-Wojcik, and J.M. Wieronska Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats Neuropharmacology 43 2002 181 187
41. L. Prut, and C. Belzung The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review Eur. J. Pharmacol. 463 2003 3 33
42. A. Ramos, O. Berton, P. Mormede, and F. Chaouloff A multiple-test study of anxiety-related behaviours in six inbred rat strains Behav. Brain Res. 85 1997 57 69
43. D.S. Reddy Role of neurosteroids in catamenial epilepsy Epilepsy Res. 62 2004 99 118
44. R.D. Rudelli, W.T. Brown, K. Wisniewski, E.C. Jenkins, M. Laure-Kamionowska, F. Connell, and H.M. Wisniewski Adult fragile X syndrome. Clinico-neuropathologic findings Acta Neuropathol. 67 1985 289 295
45. P.A. Russell Relationships between exploratory behaviour and fear: a review Br. J. Psychol. 64 1973 417 433
46. P. Simon, C. Panissaud, and J. Costentin The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine Psychopharmacology (Berl) 114 1994 597 600
47. W.P. Spooren, F. Gasparini, R. Bergmann, and R. Kuhn Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats Eur. J. Pharmacol. 406 2000 403 410
48. W.P. Spooren, A. Vassout, H.C. Neijt, R. Kuhn, F. Gasparini, S. Roux, R.D. Porsolt, and C. Gentsch Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents J. Pharmacol. Exp. Ther. 295 2000 1267 1275
49. P.K. Todd, K.J. Mack, and J.S. Malter The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95 Proc. Natl Acad. Sci. U.S.A. 100 2003 14374 14378
50. P.K. Todd, J.S. Malter, and K.J. Mack Whisker stimulation-dependent translation of FMRP in the barrel cortex requires activation of type I metabotropic glutamate receptors Brain Res. Mol. Brain Res. 110 2003 267 278
51. P.W. Vanderklish, and G.M. Edelman Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons Proc. Natl Acad. Sci. U.S.A. 99 2002 1639 1644
52. M.A. Varney, N.D. Cosford, C. Jachec, S.P. Rao, A. Sacaan, F.F. Lin, L. Bleicher, E.M. Santori, P.J. Flor, H. Allgeier, F. Gasparini, R. Kuhn, S.D. Hess, G. Velicelebi, and E.C. Johnson SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5 J. Pharmacol. Exp. Ther. 290 1999 170 181
53. R.N. Walsh, and R.A. Cummins The open-field test: a critical review Psychol. Bull. 83 1976 482 504
54. I.J. Weiler, S.A. Irwin, A.Y. Klintsova, C.M. Spencer, A.D. Brazelton, K. Miyashiro, T.A. Comery, B. Patel, J. Eberwine, and W.T. Greenough Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation Proc. Natl Acad. Sci. U.S.A. 94 1997 5395 5400
55. K.E. Wisniewski, S.M. Segan, C.M. Miezejeski, E.A. Sersen, and R.D. Rudelli The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities Am. J. Med. Genet. 38 1991 476 480
56. Q. Yan, M. Tranfaglia, and R. Bauchwitz Audiogenic Seizures and the Anticonvulsive Effect of the mGluR5 Antagonist MPEP in the fmr1-tm1Cgr Fragile X Mouse 2003 Society for Neuroscience New Orleans
57. Q.J. Yan, P.K. Asafo-Adjei, H.M. Arnold, R.E. Brown, and R.P. Bauchwitz A phenotypic and molecular characterization of the fmr1-tm1Cgr Fragile X mouse Genes Brain Behav. 3 2004 337 359
58. F. Zalfa, M. Giorgi, B. Primerano, A. Moro, A. Di Penta, S. Reis, B. Oostra, and C. Bagni The Fragile X Syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses Cell 112 2003 317 327
59. F. Zheng, and J.P. Gallagher Metabotropic glutamate receptors are required for the induction of long-term potentiation Neuron 9 1992 163 172